Acute and prolonged critical illness as different neuroendocrine paradigms

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 1827-1834

  Van Den Berghe, Greet ^a,c   De Zegher, Francis ^a   Bouillon, Roger ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c FUND FOR SCIENTIFIC RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE RESPONSE; CRITICAL ILLNESS; DEFENSE MECHANISM; DISEASE COURSE; FEEDBACK SYSTEM; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; INTENSIVE CARE; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; REVIEW; STRESS; ADRENAL CORTEX; GONAD; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; THYROID GLAND;

GROWTH HORMONE; PROLACTIN;

ADRENAL CORTEX; CRITICAL ILLNESS; GONADS; GROWTH HORMONE; HUMANS; NEUROSECRETORY SYSTEMS; PROLACTIN; THYROID GLAND;

EID: 0031732506     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.1827     Document Type: Review

References (94)

1. Cuthbertson DP. 1932 Observations on the disturbance of metabolism produced by injury to the limbs. Q J Med. 25:233-246.
2. Kinney JM, Duke JH, Long CL, Gump FE. 1970 Tissue fuel and weight loss after injury. J Clin Pathol. 23:65-72.
3. Cahill GF. 1970 Starvation in man. N Engl J Med. 12:668-675.
4. Chrousos GP. 1995 The hypothalamic-pituitary adrenal axis and immune-mediated inflammation. N Engl J Med. 332:1351-1362.
5. Noel GL, Suh HK, Stone SJG, Frantz AE. 1972 Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab. 35:840-851.
6. Ross R, Miell J, Freeman E, et al. 1991 Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin Endocrinol (Oxf). 35:47-54.
7. Voerman HJ, Strack van Schijndel RJM, de Boer H, van der Veen EA, Thijs LG. 1992 Growth hormone: secretion and administration in catabolic adult patients, with emphasis on the critically ill patient. Neth J Med. 41:229-244.
8. Wang C, Chan V, Yeung RTT. 1978 Effect of surgical stress on pituitary-testicular function. Clin Endocrinol (Oxf). 9:255-266.
9. Chopra IJ. 1997 Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab. 82:329-334.
10. Utiger RD. 1980 Decreased extrathyroidal triiodothyronine production in non-thyroidal illness: benefit or harm ? Am J Med. 69:807-810.
11. Baxter RC. 1997 Acquired growth hormone insensitivity and insulin-like growth factor bioavailability. Endocrinol Metab. 4(Suppl B):65-69.
12. Streat SJ, Beddoe AH, Hill GL. 1987 Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 27:262-266.
13. Gamrin L, Essén P, Forsberg AM, Hultman E, Wernerman J. 1996 A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med. 24:575-583.
14. Madoff RD, Sharpe SM, Fath JJ, Simmons RL, Cerra FB. 1985 Prolonged surgical intensive care. A useful allocation of medical resources. Arch Surg. 120:698-702.
15. Goins WA, Reynolds HN, Nyanjom D, Dunham CM. 1991 Outcome following prolonged intensive care unit stay in multiple trauma patients. Crit Care Med. 19:339-345.
16. Van den Berghe G, de Zegher F. 1996 Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med. 24:1580-1590.
17. Van den Berghe G, de Zegher F, Veldhuis JD, et al. 1997 The somatotropic axis in critical illness: effect of continuous GHRH and GHRP-2 infusion. J Clin Endocrinol Metab. 82:590-599.
18. Van den Berghe G, de Zegher F, Veldhuis JD, et al. 1997 Thyrotropin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone secretagogues. Clin Endocrinol (Oxf). 47:599-612.
19. Van den Berghe G, de Zegher F, Baxter RC, et al. 1998 On the neuroendocrinology of prolonged critical illness: effect of continuous thyrotropin-releasing hormone infusion and its combination with growth hormone-secretagogues. J Clin Endocrinol Metab. 83:309-319.
20. Vermes I, Bieshuizen A, Hampsink RM, Haanen C. 1995 Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab. 80:1238-1242.
21. Brown-Séquard CE. 1856 Recherches expérimentales sur la physiologie et la pathologie des capsules surrénales. C R Acad Sci [D] Paris. 43:422-425.
22. Rivier C, Vale W. 1983 Modulation of stress induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 305:325-327.
23. Dallman MF. 1993 Stress update: adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress. Trends Endocrinol Metab. 4:62-69.
24. Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology. 130:1394-1400.
25. O'Leary E, Hubbard K, Tormey W, Cunningham AJ. 1996 Laparoscopic cholecystectomy: hemodynamic and neuroendocrine responses after pneumoperitoneum and changes in position. Br J Anaesth. 76:640-644.
26. Munck A, Guyre P, Holbrook N. 1984 Physiological functions of glucocorticoids during stress and their relation to pharmacological actions. Endocr Rev. 5:25-44.
27. Starling EH. 1923 The wisdom of the body. The Harveian Oration delivered to the Royal College of Physicians, London: H.K. Lewis.
28. Cannon WB. 1932 The wisdom of the body. New York: Norton.
29. Suzuki T, Suzuki N, Daynes RA, Engleman EG. 1991 Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T-cells. Clin Immunol Immunopathol. 61:202-211.
30. Parker LN, Levin ER, Lifrak ET. 1985 Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab. 60:947-952.
31. Van den Berghe G, de Zegher F, Schetz M, Verwaest C, Ferdinande P, Lauwers P. 1995 Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf). 43:457-463.
32. Zipser RD, Davenport MW, Martin KL, et al. 1981 Hyperreninemic hypoaldosteronism in the critically ill: a new entity. J Clin Endocrinol Metab. 53:867-873.
33. Barquist E, Kirton O. 1997 Adrenal insufficiency in the surgical intensive care unit patient. J Trauma. 42:27-31.
34. Timmins AC, Cotterill AM, Cwyfan Hughes SC, et al. 1996 Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med. 24:1460-1466.
35. Hermansson M, Wickelgren RB, Hammerqvist F, et al. 1997 Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. J Clin Endocrinol Metab. 82:421-428.
36. Baxter RC. 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res. 42:140-144.
37. Ghahary A, Fu S, Shen YJ, Shankowsky HA, Tredget EE. 1994 Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients. Mol Cell Biochem. 135:171-180.
38. Ross RJM, Miell JP, Holly JMP, et al. 1991 Levels of GH-binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients. Clin Endocrinol (Oxf). 35:361-367.
39. Hartman ML, Veldhuis JD, Johnson ML, et al. 1992 Augmented growth hormone secrtory burst frequency and amplitude mediate enhanced GH secretion during a two day fast in normal men. J Clin Endocrinol Metab. 74:757-765.
40. Thissen JP, Ketelslegers J-M, Underwood LE. 1994 Nutritional regulation of insulin-like growth factors. Endocr Rev. 15:80-101.
41. Souba WW. 1997 Nutritional support. N Engl J Med 336:41-48.
42. de Zegher F, Francois I, Van Helvoirt M, Van den Berghe G. 1997 Small as a fetus and short as a child: from endogenous to exogenous growth hormone. J Clin Endocrinol Metab. 82:2021-2026.
43. Pincus SM. 1991 Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA. 88:2297-2301.
44. Hawker FH, Steward PM, Baxter RC, et al. 1987 Relationship of somatomedin-C/insulin-like growth factor-I levels to conventional nutritional indices in critically il patients. Crit Care Med. 15:732-736.
45. Van den Berghe G, de Zegher F, Bowers CY, et al. 1996 Pituitary responsiveness to growth hormone (GH) releasing hormone, GH-releasing peptide-2 and thyrotropin releasing hormone in critical illness. Clin Endocrinol (Oxf). 45:341-351.
46. Johannsson G. Rosén T, Bengtsson B-A. 1997 Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol (Oxf). 47:571-581.
47. Wartofski L, Burman KD. 1982 Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome." Endocr Rev. 3:164-167.
48. Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco GN, Mead JF. 1985 Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with non-thyroidal illness. J Clin Endocrinol Metab. 60:666-672.
49. Kaptein EM, Grieb DA, Spencer C, Wheeler WS, Nicoloff JT. 1981 Thyroxine metabolism in the low thyroxine state of critical non-thyroidal illnesses. J Clin Endocrinol Metab. 53:764-771.
50. Schlienger JL, Sapin R, Capgras T, et al. 1991 Evaluation of thyroid function after myocardial infarction. Ann Endocrinol (Paris). 52:283-288.
51. Rothwell PM, Lawler PG. 1995 Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med. 23:78-83.
52. Carr FE, Seelig S, Mariash CN, Schwartz HL, Oppenheimer JH. 1983 Starvation and hypothyroidism exert an overlapping influence on rat hepatic messenger RNA activity profiles. J Clin Invest. 72:154-163.
53. Thompson Jr P, Burman KD, Lukes YG, et al. 1980 Uremia decreases nuclear 3,5,3′-triiodothyronine receptors in rats. Endocrinology. 107:1081-1084.
54. Bacci V, Schussler GC, Kaplan TC. 1982 The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab. 54:1229-1235.
55. Kakucska I, Romero LI, Clark BD, Rondeel JM, Alex S, Emerson CH, Lechan RM. 1994 Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology. 59:129-137.
56. St Germain DL, Gallon VA. 1985 Comparative study of pituitary-thyroid economy in fasting and hypothyroid rats. J Clin Invest. 75:679-688.
57. van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. 1990 Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab. 71:1567-1572.
58. Stouthard JML, van der Poll T, Endert E, et al. 1994 Effects of acute and chronic interleukin-6 administration on the thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 79:1342-1346.
59. van der Poll T, van Zee K, Endert E, et al. 1995 Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentration in man. J Clin Endocrinol Metab 80:1341-1346.
60. Boelen A, Platvoet-ter Schiphorst MC, Bakker O, Wiersinga WM. 1995 The role of cytokines in the LPS-induced sick euthyroid syndrome in mice. J Endocrinol. 146:475-483.
61. Carlin K, Carlin S. 1993 Possible etiology for euthyroid sick syndrome. Med Hypotheses. 40:38-43.
62. Everts ME, Visser TJ, Moerings EP, et al. 1994 Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology. 135:2700-2707.
63. Lim CF, Doctor R, Visser TJ, et al. 1993 Inhibition of thyroxine transport into cultured rat hepatocytes by serum of non-uremic critically ill patients: effects of bilirubin and non-esterified fatty acids. J Clin Endocrinol Metab. 76:1165-1172.
64. Gardner DF, Kaplan MM, Stanley CA, Utiger RD. 1979 Effect of triiodothyronine replacement on the metabolic and pituitary responses to starvation N Engl J Med. 300:579-584.
65. Fliers E, Guldenaar SEF, Wiersinga WM, Swaab DF. Thyrotropin-releasing hormone gene expression in the human hypothalamus in relation to non-thyroidal illness. Proc of the 79th Annual Meet of The Endocrine Soc. 1997; 129.
66. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. 1989 Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 17:975-978.
67. Faglia G, Ferrari C, Beck-Peccoz P, Spada A, Travaglini P, Ambrosi B. 1973 Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal humans. Horm Metab Res. 5:289-291.
68. Van den Berghe G, de Zegher F, Lauwers P. 1994 Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf). 41:731-737.
69. Van den Berghe G, de Zegher F, Vlasselaers F, et al. 1996 Thyrotropin releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin and growth hormone. Crit Care Med. 24:590-595.
70. Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlin S, Kaplan MM. 1993 Reduced tissue thyroid hormone levels in fatal illness. Metabolism. 42:1102-1108.
71. Vaughan GM, Mason AD, McManus WF, Pruitt BA jr. 1985 Alterations of mental status and thyroid hormones after thermal injury. J Clin Endocrinol Metab. 60:1221-1225.
72. Brent GA, Hershman JM. 1986 Thyroxine therapy in patients with severe non-thyroidal illnesses and low serum thyroxine concentrations. J Clin Endocrinol Metab. 63:1-7.
73. Becker RA, Vaughan GM, Ziegler MG, et al. 1982 Hypermetabolic low triiodothyronine syndrome in burn injury. Crit Care Med. 10:870-875.
74. Klibanski A, Beitens IZ, Badger TM, Little R, McArthur J. 1981 Reproductive function during fasting in man. J Clin Endocrinol Metab. 53:258-266.
75. Veldhuis JD, Iranmanesh A, Evans WS, Lizarralde G, Thorner MO, Vance ML. 1993 Amplitude suppression of the pulsatile mode of immunoradiometric LH release in fasting-induced hypoandrogenemia in normal men. J Clin Endocrinol Metab. 76:587-593.
76. Wang C, Chan V, Tse TF, Yeung RT. 1978 Effect of acute myocardial infarction on pituitary testicular function. Clin Endocrinol (Oxf). 9:249-253.
77. Vogel AV, Peake GT, Rada RT. 1985 Pituitary-testicular axis dysfunction in burned men. J Clin Endocrinol Metab. 60:658-665.
78. Lephart ED, Baxter CR, Parker CR jr. 1987 Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab. 64:842-848.
79. Kreutz LD, Rose RM, Jennings JR. 1972 Suppression of plasma testosterone levels and psychological stress: a longitudinal study of young men in officer candidate school. Arch Gen Psychiatry. 26:479-482.
80. Aakvaag A, Bentdal O, Quigstad K, Walstad P, Ronningen H, Fonnum F. 1978 Testosterone and testosterone binding globulin in young men during prolonged stress. Int J Androl. 1:22-31.
81. Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD. 1994 Luteinizing hormone secretion and hypoandrogenemia in critically ill men: effect of dopamine. Clin Endocrinol (Oxf). 41:563-569.
82. Dong Q, Hawker F, McWilliam D, Bangah M, Burger H, Handelsman DJ. 1992 Circulating immunoreactive inhibin and testosterone levels in patients with critical illness. Clin Endocrinol (Oxf). 36:399-404.
83. Rivier C, Vale W. 1989 In the rat, interleukin 1-α acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. Endocrinology. 124:2105-2109.
84. Guo H, Calkins JH, Sigel MM, Lin T. 1990 Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis. Endocrinology. 127:1234-1239.
85. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. 1985 Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab. 60:444-450.
86. Spratt DI, Cox P, Orav J, Moloney J, Bigos T. 1993 Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab. 76:1548-1554.
87. Van Steenbergen W, Naert J, Lambrecht S, Scheys I, Lesaffre E, Pelemans W. 1994 Suppression of gonadotropin secretion in the hospitalized postmenopausal female as an effect of acute illness. Neuroendocrinology. 60:165-172.
88. Cicero TJ, Bell RD, Wiest WG, Allison JH, Polakoski K, Robins E. 1975 Function of the male sex organs in heroin and methadone users. N Engl J Med. 292:882-887.
89. Tweedle D, Walton C, Johnston IDA. 1972 The effect of an anabolic steroid on postoperative nitrogen balance. Br J Clin Pract. 27:130-132.
90. Ben-Jonathan N. 1985 Dopamine: a prolactin-inhibiting hormone. Endocr Rev. 6:564-589.
91. Reichlin S. 1993 Neuroendocrine-immune interactions. N Engl J Med. 329:1246-1253.
92. Carrier M, Wild J, Pelletier C, Copeland JG. 1990 Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation. Ann Thorac Surg. 49:129-132.
93. Devins SS, Miller A, Herndon BL, O'Toole L, Reisz G. 1992 Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med. 263:9682-9685.
94. Meakins JL, Pietsch JB, Bubenick O, et al. 1977 Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg. 188:241-250.